Our founder and CEO Marshall Fordyce, M.D. recently returned to Biotech2050 to discuss Vera's evolution to where we are today, with a promising lead clinical program in #IgANephropathy and the potential to explore additional diseases where we may transform the standard of care. Thank you Rahul Chaturvedi for the opportunity to reflect on our journey and key insights we gained along the way. Listen to the full episode here: https://lnkd.in/eqHFpe4B
Delighted to unveil the newest #Biotech 2050 episode with Marshall Fordyce, M.D. Fordyce, the innovative Founder & CEO of Vera Therapeutics, Inc.! 🎙️ In this episode, Host Rahul Chaturvedi joins Marshall as they delve into his transformative journey from physician to biotech entrepreneur, offering invaluable perspectives on the biotech industry. Discover how Vera Therapeutics pivoted to focus on IG nephropathy and their groundbreaking work with atacicept, a promising B-cell modulator. Key highlights include: 🔹 The importance of scientific rigor and adaptability 🔹 Navigating the biotech landscape 🔹 Future outlook on autoimmune disease treatments Whether you're an aspiring entrepreneur or a seasoned professional, Marshall's insights on maintaining a lean operating model and driving innovation are a must-listen. 🎧 Tune in now and get inspired by the future of autoimmune disease treatments: https://lnkd.in/eaq7isNN #Biotech #Autoimmune #Innovation #Healthcare #BiotechBreakthroughs #Podcast #MedicalResearch #ClinicalTrials #DrugDevelopment #HealthcareInnovation #Entrepreneurship